We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
+34.77%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$1.54B
AUM Growth
-$138M
(-8.2%)
Cap. Flow
-$300M
Cap. Flow
% of AUM
-19.47%
Top 10 Holdings %
Top 10 Hldgs %
9.99%
Holding
2,498
New
653
Increased
404
Reduced
598
Closed
777
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CY
Cypress Semiconductor
CY
|
+$17M |
| 2 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$15M |
| 3 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$14.8M |
| 4 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$11.6M |
| 5 |
CZR
Caesars Entertainment Corporation
CZR
|
+$11.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.77M |
| 2 |
Cigna
CI
|
+$2.57M |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.48M |
| 4 |
Baidu
BIDU
|
+$2.2M |
| 5 |
Bausch Health
BHC
|
+$2.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.98% |
| 2 | Technology | 4.63% |
| 3 | Consumer Discretionary | 3.8% |
| 4 | Industrials | 1.77% |
| 5 | Financials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
301
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.41M | 0.09% |
41,068
+22,768
| +124% | +$273K |
|
|
FL
302
PUT
DELISTED
Foot Locker
FL
| $1.41M | 0.09% |
36,100
-19,900
| -36% | -$838K |
|
|
ESPR
303
PUT
DELISTED
Esperion Therapeutics
ESPR
| $1.41M | 0.09% |
23,600
-16,500
| -41% | -$742K |
|
304
CALL
Teradata
TDC
$2.68B
| $1.41M | 0.09% |
52,500
+21,500
| +69% | +$598K |
|
305
CALL
Procter & Gamble
PG
$343B
| $1.4M | 0.09% |
11,200
+2,700
| +32% | +$330K |
|
|
GBT
306
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.4M | 0.09% |
17,600
-76,500
| -81% | -$4.53M |
|
|
CYBR
307
DELISTED
CyberArk
CYBR
| $1.39M | 0.09% |
11,947
+6,871
| +135% | +$771K |
|
308
Aurinia Pharmaceuticals
AUPH
$1.97B
| $1.39M | 0.09% |
+68,570
| New | +$632K |
|
309
PUT
Deckers Outdoor
DECK
$13.3B
| $1.39M | 0.09% |
49,200
-40,200
| -45% | -$1.07M |
|
310
CALL
HP
HPQ
$23.5B
| $1.39M | 0.09% |
67,400
+54,600
| +427% | +$1.03M |
|
311
PUT
Helmerich & Payne
HP
$3.53B
| $1.38M | 0.09% |
30,300
+26,200
| +639% | +$1.05M |
|
312
CALL
Atlassian
TEAM
$22B
| $1.36M | 0.09% |
11,300
-25,000
| -69% | -$3.04M |
|
313
Duke Energy
DUK
$102B
| $1.36M | 0.09% |
+14,900
| New | +$1.37M |
|
314
CALL
Encompass Health
EHC
$11.2B
| $1.34M | 0.09% |
+24,386
| New | +$1.32M |
|
315
CALL
Agios Pharmaceuticals
AGIO
$2.16B
| $1.34M | 0.09% |
28,100
-18,700
| -40% | -$707K |
|
316
PUT
DXC Technology
DXC
$1.63B
| $1.34M | 0.09% |
35,700
+3,000
| +9% | +$97.9K |
|
317
PUT
B&G Foods
BGS
$285M
| $1.34M | 0.09% |
+74,800
| New | +$1.26M |
|
|
MRSH
318
CALL
Marsh
MRSH
$86.3B
| $1.34M | 0.09% |
12,000
+6,100
| +103% | +$637K |
|
319
Galicia Financial Group
GGAL
$7.92B
| $1.32M | 0.09% |
81,600
+59,000
| +261% | +$779K |
|
320
PUT
Dentsply Sirona
XRAY
$2.59B
| $1.32M | 0.09% |
23,400
+13,700
| +141% | +$764K |
|
321
CALL
lululemon athletica
LULU
$13B
| $1.32M | 0.09% |
5,700
-11,600
| -67% | -$2.47M |
|
322
Ciena
CIEN
$55.3B
| $1.31M | 0.08% |
30,597
+30,297
| +10,099% | +$1.15M |
|
|
ANDAU
323
DELISTED
Andina Acquisition Corp. III Unit
ANDAU
| $1.3M | 0.08% |
123,400
-1,600
| -1% | -$16.8K |
|
|
PARA
324
CALL
DELISTED
Paramount Global Class B
PARA
| $1.3M | 0.08% |
31,000
-17,500
| -36% | -$678K |
|
|
SBNY
325
PUT
DELISTED
Signature Bank
SBNY
| $1.3M | 0.08% |
+9,500
| New | +$1.19M |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Walleye Capital held 2,498 positions worth $1.54B, down 8.2% from $1.68B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Walleye Capital withdrew a net $300M in Q4 2019, closing 777 positions and reducing 598 holdings. Its most notable exit was Cigna, an estimated $2.57M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 5% of assets, up from 1.9% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Walleye Capital opened a new position in Cypress Semiconductor worth $17M.
- Walleye Capital's largest Q4 2019 buy was Cypress Semiconductor: 727,918 shares worth $17M.
- Walleye Capital added most to Acacia Communications Inc in Q4 2019, an estimated $8.45M increase.
- Walleye Capital's biggest Q4 2019 reduction was Humana, cutting an estimated $2.77M.
- Walleye Capital fully exited Cigna in Q4 2019, selling an estimated $2.57M.
- Walleye Capital's ten largest holdings make up 10% of its $1.54B portfolio in Q4 2019.
- Walleye Capital opened 653 new positions and closed 777 in Q4 2019.
- Walleye Capital's portfolio value fell 8.2% quarter-over-quarter to $1.54B.
Based on Walleye Capital's 13F filing for Q4 2019, filed 14 Feb 2020.